ANTARES PHARMA INC's ticker is and the CUSIP is 36642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $9,000 | +50.0% | 5,455 | 0.0% | 0.00% | – |
Q2 2016 | $6,000 | 0.0% | 5,455 | -26.8% | 0.00% | – |
Q1 2016 | $6,000 | 0.0% | 7,455 | +51.5% | 0.00% | – |
Q4 2015 | $6,000 | -96.8% | 4,922 | -95.5% | 0.00% | -100.0% |
Q3 2015 | $186,000 | -27.6% | 109,122 | -11.8% | 0.00% | -25.0% |
Q2 2015 | $257,000 | +78.5% | 123,680 | +133.2% | 0.00% | +100.0% |
Q1 2015 | $144,000 | +37.1% | 53,043 | +30.2% | 0.00% | 0.0% |
Q4 2014 | $105,000 | +23.5% | 40,743 | -12.2% | 0.00% | +100.0% |
Q3 2014 | $85,000 | -18.3% | 46,397 | +18.9% | 0.00% | -50.0% |
Q2 2014 | $104,000 | -71.5% | 39,020 | -62.6% | 0.00% | -66.7% |
Q1 2014 | $365,000 | -39.2% | 104,273 | -22.1% | 0.01% | -33.3% |
Q4 2013 | $600,000 | +31.9% | 133,860 | +19.4% | 0.01% | 0.0% |
Q3 2013 | $455,000 | – | 112,109 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
McAdams Wright Ragen, Inc. | 244,438 | $992,000 | 0.08% |
SALEM INVESTMENT COUNSELORS INC | 131,120 | $532,000 | 0.07% |
GROUP ONE TRADING, L.P. | 112,109 | $455,000 | 0.01% |
TEACHERS ADVISORS, LLC | 153,502 | $623,000 | 0.00% |
TIAA CREF INVESTMENT MANAGEMENT LLC | 454,815 | $1,847,000 | 0.00% |